Exploring medical potential of cannabinoids
Evaluating the medicinal use of cannabinoids represents an area of massive untapped potential, especially considering its upcoming legalization in Canada. Currently, a significant proportion of medical cannabis research is based on self-reported use and outcomes, rather than carefully-designed research studies. Here, we aim to better understand the impact of cannabis administration in adults with obesity or tobacco dependence and its potential as an opioid-sparing medicine, using randomized controlled clinical trials. Results of these investigations may potentially drive the development of novel pharmacological approaches for the treatment of these conditions.
View Full Project DescriptionBernard Le Foll
Spectrum Therapeutics;10607410 Canada Inc (STAR/CHI)
Life Sciences
Manufacturing; Professional, scientific and technical services
University of Toronto
Accelerate